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Abstract
Background: Constitutive and regulated internalization of cell surface proteins has been extensively investigated.
The regulated internalization has been characterized as a principal mechanism for removing cell-surface receptors
from the plasma membrane, and signaling to downstream targets of receptors. However, so far it is still not known
whether the functional properties of remaining (non-internalized) receptor/channels may be regulated by internalization
of the same class of receptor/channels. The N-methyl-D-aspartate receptor (NMDAR) is a principal subtype of glutamate-
gated ion channel and plays key roles in neuronal plasticity and memory functions. NMDARs are well-known to undergo
two types of regulated internalization – homologous and heterologous, which can be induced by high NMDA/glycine
and DHPG, respectively. In the present work, we investigated effects of regulated NMDAR internalization on the activity of
residual cell-surface NMDARs and neuronal functions.
Results: In electrophysiological experiments we discovered that the regulated internalization of NMDARs not only
reduced the number of cell surface NMDARs but also caused an inhibition of the activity of remaining (non-internalized)
surface NMDARs. In biochemical experiments we identified that this functional inhibition of remaining surface NMDARs
was mediated by increased serine phosphorylation of surface NMDARs, resulting from the activation of protein kinase D1
(PKD1). Knockdown of PKD1 did not affect NMDAR internalization but prevented the phosphorylation and inhibition of
remaining surface NMDARs and NMDAR-mediated synaptic functions.
Conclusion: These data demonstrate a novel concept that regulated internalization of cell surface NMDARs not only
reduces the number of NMDARs on the cell surface but also causes an inhibition of the activity of remaining surface
NMDARs through intracellular signaling pathway(s). Furthermore, modulating the activity of remaining surface receptors
may be an effective approach for treating receptor internalization-induced changes in neuronal functions of the CNS.
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Background
Extensive investigations have characterized mechanisms
underlying constitutive and regulated internalization of
cell surface proteins, which include pathways dependent
or independent of clathrin or caveolae [1–3]. The intern-
alization of cell-surface receptors or channels has been
found to play important roles in regulation of immune
responses, neurotransmitter release, development, and
organismal homeostasis [1–4]. Internalization initiated
by activating cell-surface receptors was first conceptual-
ized as a mechanism for terminating signaling and for
preventing further receptor activation by extracellular
ligands. Subsequently, receptors that had undergone
activity-induced internalization were found to signal [5],
and to do so by engaging signaling pathways distinct
from those engaged by the receptors while they were on
the cell surface. However, it is not known whether the
functional properties of remaining (non-internalized) re-
ceptor/channels may be regulated by internalization of
the same class of receptor/channels.
The NMDAR is a principal subtype of glutamate-gated
ion channel and plays key roles in neuronal plasticity
and memory functions [6–10]. NMDARs are well-
known to undergo two types of regulated internalization
[11] – homologous and heterologous – which can be
induced respectively by stimulating both the glutamate
and glycine binding sites on the receptor [11, 12] and by
stimulating G-protein coupled receptors such as the
group 1 metabotropic glutamate receptors (mGluRs)
[13–17]. In the present work, by using a combination of
electrophysiological, biochemical, and genetic approaches,
we determined that both types of regulated NMDAR
internalization activate PKD1 signaling, which then
suppresses the activity of non-internalized cell-surface
NMDARs and NMDAR-mediated synaptic responses.
Results
Regulated internalization of NMDARs causes inhibition of
single-channel activity of cell-surface NMDARs
Regulated NMDAR internalization causes significant re-
ductions in whole-cell currents mediated by NMDARs
[12–14] (and data not shown). Here, we questioned
whether the activity of the non-internalized, residual
NMDARs may be affected by NMDAR internalization.
To answer this question, we recorded NMDAR single-
channel activity in cell-attached patches on cultured
hippocampal neurons and induced heterologous or
homologous internalization of NMDARs outside the
patch (see cartoons in Fig. 1a and e). Heterologous intern-
alization was induced by treating the neurons with the
group 1 mGluR agonist, (S)-3,5-Dihydroxyphenylglycine
(DHPG, 50 μM) [13, 14]. Consistent with previous findings
[13–17], application of DHPG (50 μM) caused endocytosis
of both NMDA (Additional file 1: Figure S1 and Additional
file 2: Figure S2) and AMPA receptors (data not shown).
Homologous internalization was induced by treating
with high NMDA/glycine (1 mM NMDA and 100 μM
glycine, N + G) [12]. We confirmed that each treat-
ment induced statistically significant reductions in
cell-surface NMDAR proteins (see Additional file 1:
Figure S1 and Additional file 2: Figure S2). Moreover,
the reductions in cell-surface expression were blocked
by bath application of a membrane-permeant dynamin
inhibitory peptide (DIP), Myr-4–QVPSRPNRAP (50 μM,
Additional file 1: Figure S1), which blocks dynamin-
dependent receptor internalization [12, 18, 19]. By contrast,
applying a scrambled form of DIP (sDIP, Myr-4–
QPPASNPRVR, 50 μM) did not prevent the reduction
in NMDAR cell-surface expression induced by DHPG
or by high NMDA/glycine treatment [12, 18, 19]
(Additional file 1: Figure S1).
NMDAR single-channel currents recorded in the cell-
attached patch configuration were evoked with NMDA
(10 μM) and glycine (3 μM) added into the patch pipette
(see cartoons in Fig. 1a and e). In the cell-attached con-
figuration, recorded NMDARs are isolated by the patch
electrode from the extracellular bath environment and,
therefore, will not be directly stimulated by bath-applied
lipophobic agents [20, 21]. Taking advantage of this re-
cording configuration, we investigated the activity of the
isolated NMDAR single-channels before and after in-
ternalization of remote NMDARs (outside the patch) in-
duced by bath application of DHPG (50 μM) (Fig. 1a–d)
or bath application of high glycine (100 μM) in the pres-
ence of NMDA (1 mM) (Fig. 1e–h). Treatment with a
high concentration of NMDA (1 mM) in the presence of
a low concentration of glycine (3 μM) did not induce
NMDAR internalization [12] (N in Additional file 1:
Figure S1B). To prevent excitotoxic effects which can
be induced by NMDA and/or glycine, a standard extra-
cellular solution in which NaCl and KCl were replaced
by Na2SO4 and Cs2SO4 was used in all of the reported
biochemical and electrophysiological experiments. Consist-
ent with previous findings [20, 22], no damage of neurons
bathed with this standard solution was observed following
NMDA and/or glycine application.
Before bath applying DHPG the overall channel open
probability (Po, ratio of total open time versus recording
time), mean open time (to) and the duration of bursts
(Bs), clusters (Cs) and super-clusters (Sc) of recorded
NMDAR channels (n = 11 patches) were 0.02 ± 0.007,
1.7 ± 0.2 ms, 2.8 ± 0.4 ms, 7.6 ± 1.3 ms, and 95 ± 33 ms,
respectively. After the bath application of DHPG, Po, to,
Bs, Cs, and Sc were significantly reduced (Fig. 1a and d),
without a change in the single-channel conductance
(Fig. 1c). The group 1 mGluR antagonist, 6-Methyl-2-
(phenylethynyl)pyridine (MPEP,10 μM) prevented the ef-
fects produced by DHPG (Fig. 1d). Bath application of
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high glycine (100 μM) in the presence of NMDA (1 mM)
also caused significant reduction in NMDAR single channel
activity recorded in cell attached patches (Fig. 1e and h).
The glycine binding site blocker, L689560 (1 μM, Tocris,
Bristol, UK), prevented the effect of glycine application
(Fig. 1h).
While application of the dynamin inhibitor, DIP, alone
did not significantly change NMDAR single channel ac-
tivity (Po, to, Bs, Cs, and Sc were respectively 95 ± 18 %,
96 ± 4 %, 97 ± 11 %, 112 ± 12 % and 88 ± 6 % of those
prior to the DIP application), DIP co-application signifi-
cantly reduced the inhibition of NMDAR channels in-
duced by bath application of either DHPG (Fig. 1d) or
glycine (Fig. 1h). sDIP had no such effect (Fig. 1d and h).
These findings implied that the activity of NMDARs
in the cell-attached patch is inhibited after either
heterologous or homologous internalization of remote
NMDARs. However, it remained unclear whether the
activity changes observed in cell-attached recordings
might be induced by internalization of recorded NMDARs
within the membrane patch. To address this issue, we pre-
vented internalization of NMDARs by using an antibody
complex [23, 24] (X-link), comprised of an antibody
against the extracellular loop of the GluN1 subunit
(mouse IgG, BD Biosciences, San Jose, CA) and a second-
ary antibody against mouse IgG (goat-anti-mouse IgG,
G-Bioscience, St. Louis, MO). We determined that the
X-link (2.5 μg/ml of GluN1 antibody and 5 μg/ml of
b
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Fig. 1 NMDAR single-channel activity is down-regulated by bath application of DHPG or high NMDA/glycine. NMDAR-mediated currents evoked
by including NMDA (10 μM) and glycine (3 μM) in recording pipettes in the cell-attached configuration. Recorded NMDARs were isolated by the
patch electrode from the extracellular bath environment (see cartoons in a and e). a an example of records of NMDA single-channel open probability
(Po, bin: 10 s) before, during and after bath application of DHPG (50 μM). b examples of recorded single-channel current traces. O: Open level; C: Closed
level. An example of I-V relationships before (open circles) and post (filled triangles) DHPG application is shown in (c). d summary data (mean ± SEM)
showing relative changes in overall Po, mean open time (to), and lengths of burst (Bs), cluster (Cs) and super-cluster (Sc) when compared with that before
the bath application of DHPG (control, dashed line). Effects of DHPG (50 μM) were also examined in neurons treated with MPEP (10 μM, DHPG/MPEP),
DIP (50 μM, DHPG/DIP), or sDIP (50 μM, DHPG/sDIP). Examples of records of NMDA single-channel open probability, single-channel current traces and
I-V relationships before and during bath application of a high concentration of glycine (100 μM) in the presence of 1 mM NMDA (N + G) are shown in
(e, f and g), respectively. h summary data showing relative changes in channel activity when compared with that before the bath application of glycine
(control, dashed line). Effects of bath application of N + G were also examined in neurons treated with L689560 (1 μM, N + G/L689560), DIP (N + G/DIP)
or sDIP (N + G/sDIP). Values in brackets indicate number of patches recorded. *: P < 0.05 (paired t-test) in comparison with control before bath application
of DHPG or glycine
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goat-anti-mouse IgG) prevented the internalization of
NMDARs induced by the bath application of high
NMDA/glycine (1 mM NMDA and 100 μM glycine), but
did not alter the basal level of NMDAR expression
(Fig. 2a).
We then examined the activity of surface NMDARs
when these channels were immobilized by the X-link. In-
clusion of the X-link in the recording pipettes did not sig-
nificantly affect the activity of recorded NMDAR channels
(Fig. 2b). Inclusion of high NMDA/glycine (N + G) in the
recording pipette caused a decline in NMDAR channel Po
recorded in cell-attached patches (Fig. 3a), implying the
internalization of recorded NMDARs. Such reductions
were not observed when the X-link was included in re-
cording pipette containing high NMDA/glycine (1 mM
NMDA and 100 μM glycine) (Fig. 3b), suggesting that the
X-link added into the recording pipettes immobilized
surface NMDARs recorded and thereby prevented the
Po reduction.
We then recorded NMDAR single channel currents
evoked by including a high concentration of NMDA (1 mM)
and a low concentration of glycine (3 μM), which
does not cause NMDAR internalization [12] (N in
Additional file 1: Figure S1B), in the pipette solution
containing the X-link (Fig. 3c). We found that bath
application of glycine at the high concentration (100 μM)
capable of inducing NMDAR internalization still resulted
in a reduction in Po of recorded channels which had been
immobilized with the X-link (Fig. 3c). In contrast, bath
application of the X-link, which immobilized remote
NMDARs, prevented Po reduction in neurons recorded
with pipettes filled either with (Fig. 3d) or without (Fig. 3e)
the X-link. Thus, the inhibition of NMDARs recorded in
cell-attached patches following bath application of glycine
at 100 μM was unlikely to be induced by the internaliza-
tion of recorded receptors within membrane patches but
instead by the internalization of remote NMDARs. Taken
together, our data demonstrate that regulated internaliza-
tion of cell surface NMDARs not only reduces the number
of NMDARs expressed on the cell surface but also causes
an inhibition of the activity of non-internalized NMDARs.
Regulated NMDAR internalization causes increased serine
phosphorylation of surface NMDARs
Phosphorylation regulation has been recognized as an
important mechanism underlying the regulation of
NMDA receptor trafficking and channel functions [25–29].
To understand mechanisms underlying the activity regula-
tion of non-internalized cell surface NMDARs by NMDAR
internalization, we examined remaining NMDARs located
at the synaptic plasma membrane (LP1) [24, 30, 31] of neu-
rons after NMDAR internalization. When compared with
that in neurons treated only with culture medium (control),
no significant change in serine phosphorylation was de-
tected in the GluN1 subunit following the treatment with
high NMDA/glycine (Fig. 4a). However, the serine phos-
phorylation of the GluN2A subunit was significantly in-
creased following either DHPG (Fig. 4b) or high NMDA/
glycine application (Fig. 4c). No such increase was induced
by DHPG in neurons treated with DIP (Fig. 4b). Compared
with controls, no phosphorylation increase was induced by
vehicle or NMDA (1 mM) in the presence of a low concen-
tration of glycine (3 μM) or by high NMDA/glycine in neu-
rons treated with DIP (50 μM), staurosporine (1 μM) or
L689560 (10 μM) (Fig. 4c). The serine phosphorylation in-
crease was not affected by sDIP (50 μM). Either monensin
(10 μM) or chloroquine (200 μM), blocking receptor recyc-
ling pathways [32–34], produced no effect on the phos-
phorylation increase induced by bath application of high
NMDA/glycine (Fig. 4c). Application of monensin or
chloroquine alone did not induce any significant
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Fig. 2 Effects of the X-link consisting of mouse GluN1 antibody and goat-anti-mouse IgG on NMDAR endocytosis and gating Blots shown in (a)
are examples of Western analysis performed with antibodies against the GluN1 subunit (GluN1, upper blot) and actin (Actin, lower blot). The
loaded cell lysates were prepared from cultured neurons treated without (“-”) or with (“+”) high NMDA/glycine (N + G: 1 mM NMDA and 100 μM
glycine) in the absence (“-”) or presence (“+”) of X-link consisting of 5 μg/ml goat-anti-mouse IgG and 0.5, 2.5 or 5 μg/ml GluN1 antibody, as indi-
cated above the blots. Immediately after the treatment, the cell membrane impermeable crosslinker, BS3 [Bis(sulfosuccinimidyl) suberate] , was
applied to neurons at 4 °C as indicated with “+” below the blots. The ratio of the band intensity showing intracellular GluN1 subunit protein
versus that of actin protein was calculated and normalized to the ratio in neurons without any treatment except BS3 (=100 %, control, dashed line
in bar graphs). Bar graphs show summary data (mean ± SEM). ##: P < 0.01 (independent t-test) in comparison with control. b Summary data
showing single-channel activity of NMDARs evoked by NMDA (10 μM) and glycien (3 μM) added into recording pipettes with (filled bars) or without
(open bars) inclusion of X-link consisting of 2.5 μg/ml GluN1 antibody and 5 μg/ml goat-anti-mouse IgG
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Serine phosphorylation in the GluN2B subunit was also
increased following application of either high NMDA/
glycine or DHPG. These increases were prevented by
either DIP or staurosporine (Fig. 4d).
To examine the mechanisms underlying internalization-
induced serine phosphorylation, recombinant GluN1-1a/
GluN2A or GluN1-1a/GluN2B receptors were expressed
in HEK293 cells and used to identify the site(s) of
NMDAR phosphorylation. We found that after 10 min
treatment with high NMDA/glycine there were significant
reductions in surface expression of these receptors
(Additional file 3: Figure S3A and B). A significant reduc-
tion was also noted in surface GluN1-1a/GluN2A1-857 re-
ceptors (Additional file 3: Figure S3C), in which the C-tail
of the GluN2A subunit was truncated immediately after
aa 857. However, no significant reduction in surface
GluN1-1a/GluN2B1-857 receptors was observed, in which
the C-tail of the GluN2B subunit was truncated after aa
857 (Additional file 3: Figure S3D). These findings indicate
that internalization of GluN2B-containing receptors is
prevented by the C-tail truncation.
Similar to NMDARs in cultured neurons (see Fig. 4b–d),
we found significant increases in serine phosphorylation in
both wild-type GluN2A and GluN2B subunits after
NMDAR internalization in receptors expressed heterolo-
gously (Additional file 4: Figure S4A and B). However, such
increases were not detected in either GluN2A1-857 or
GluN2B1-857 mutants (Additional file 4: Figure S4A and
B). These findings show not only that internalization of
NMDARs is tightly regulated by subunit-specific mecha-
nisms [35–38], but also provided another line of evidence
suggesting that the event of NMDAR internalization acts as
an upstream signal activating downstream pathway(s) that,
in turn, phosphorylate(s) remaining surface NMDARs.
We then generated truncation mutations in the
GluN2A C-tail immediately after aa 1396, 1415, 1419, or
1424, respectively (Additional file 4: Figure S4C), and
found that serine 1416 and 1420 residues might be the
targets of phosphorylation in the GluN2A subunit
(Additional file 4: Figure S4D). By mutating these ser-
ines to phenylalanines, we identified that serine 1416
(S1416) in the GluN2A subunit is a key residue being
phosphorylated following internalization of GluN1-1a/
GluN2A receptors in HEK293 cells (Additional file 4:
Figure S4E). To confirm this mechanism in neurons, an




















































































































Fig. 3 The activity of remaining surface NMDARs is down-regulated by the internalization of remote NMDARs. Averages of the normalized Po (bin: 10 s)
are shown in a - e. For recordings shown in (a and b), NMDAR-mediated currents were evoked by including high NMDA/glycine (N + G: 1 mM NMDA
and 100 μM glycine) in recording pipettes. Po recorded was normalized to the Po during the first bin (control, =100 %). For recordings shown
in (c, d and e), NMDAR-mediated currents were evoked by including NMDA (1 mM) and glycine (3 μM) in recording pipettes. Po shown in (c, d and e)
was normalized to the mean values of Po (control, = 100 %) before the bath application of glycine at 100 μM. Thick lines indicate X-link
applied. *: P < 0.05 (one-way ANOVA test) in comparison with Po of the first bin in (a) or with control before bath application of glycine in (c)
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(pS1416) in the GluN2A subunit (anti-pS1416) was
raised (Additional file 5: Figure S5A–D). A significant
increase in serine phosphorylation of the GluN2A sub-
unit was detected with anti-pS1416 after NMDAR in-
ternalization in cultured neurons (Additional file 5:
Figure S5E). This established that the event of NMDAR
internalization causes increases in serine phosphoryl-
ation of remaining surface NMDARs in neurons.
The increase in NMDAR phosphorylation is induced by
PKD1 activation
A large number of studies have shown that PKC and PKA
may phosphorylate NMDARs at serine residues and
thereby modulate NMDAR activity [25, 27, 39–48]. We
thus examined whether PKA or any one of the PKC iso-
forms including PKCμ (which is now classified as PKD1
[49, 50]) might act as a downstream factor activated by
the event of NMDAR internalization. The activation status
of PKC isoforms [51–54] (Fig. 5a and d), PKA [55] (Fig. 5b
and d) or PKD1 [56] (Fig. 5c and e) was thus examined
with specific antibodies which selectively detect the en-
zyme activity-related autophosphorylation. No significant
change in the phosphorylation of these enzymes was
found after NMDAR internalization except for PKD1
(Fig. 5). Blocking NMDAR internalization prevented the





































































































Fig. 4 NMDAR internalization causes increases in serine phosphorylation of surface NMDARs. Blots shown in (a - d) are examples of experiments,
in which NMDA GluN1 (a), GluN2A (b and c) or GluN2B (d) proteins was immunoprecipitated from the synaptic plasma membrane (LP1) of
cultured neurons treated with agents in bath as indicated underneath the blots. The same filters were then stripped off and successively probed
with anti-phosphoserine antibody (pSer, upper blots) and NMDAR antibodies (lower blots) for the GluN1 (a), GluN2A (b and c) or GluN2B (d) subunit. The
ratio of band intensity showing phosphorylated versus that of total GluN1, GluN2A or GluN2B subunit proteins was normalized to the ratio in neurons
treated only with culture medium (control, = 100 %, dashed line in bar graphs). Bar graphs show summary data (mean ± SEM). M: culture medium (M),
V: vehicle, N: NMDA (1 mM), N + G: high NMDA/glycine (1 mM NMDA and 100 μM glycine). Effects of DHPG (50 μM) were also examined in neurons
treated with DIP (50 μM, DHPG/DIP), staurosporine (1 μM, DHPG/Stau) or MPEP (10 μM, DHPG/MPEP); Effects of N + G were also examined in
neurons treated with DIP (N + G/DIP), sDIP (N + G/sDIP), staurosporine (1 μM, N + G/Stau), L689560 (10 μM, N + G/L689560), monensin
(10 μM, N + G/momemsin) or chloroquine (200 μM, N + G/chloroquine). #, ##: P < 0.05, 0.01 (Independent t-test) in comparison with control (M).
Values in brackets indicate the number of experimental repeats
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To determine the role of PKD1 in NMDAR phosphoryl-
ation, we examined the effects of PKD1 immuno-purified
from neurons in vitro (Additional file 6: Figure S6A and B).
The GluN2A C-terminal fragment protein (aa 1096–1464,
5 μg), which was purified from a bacterial expression
system [57, 58], was incubated in vitro with a similar
amount of PKD1 immuno-purified respectively from neu-
rons treated with culture medium, vehicle or high NMDA/
glycine (Additional file 6: Figure S6A). Incubation with
PKD1 purified from neurons treated with high NMDA/
glycine caused significantly elevated serine phosphoryl-
ation of the GluN2A C-terminal fragment when com-
pared with those induced by PKD1 purified from neurons
treated with culture medium or vehicle (Additional file 6:
Figure S6B).
Furthermore, we found that the application of recombin-
ant PKD1 protein in active form (SignalChem, Richmond,
BC) into neurons produced a dose-dependent inhibition of
NMDAR currents recorded in the whole-cell configuration
(Additional file 6: Figure S6C). Similar effects of PKD1 were
also found on GluN1-1a/GluN2A or GluN1-1a/GluN2B
receptors expressed in HEK cells (Additional file 6:
Figure S6D and E). This inhibitory effect of PKD1
was prevented by S1416F mutation in GluN2A (Additional
file 6: Figure S6D) or by C-tail truncation from aa 858 in
the GluN2B subunit (Additional file 6: Figure S6E). Thus,
we conclude that NMDARs can be phosphorylated and
thereby down-regulated by PKD1. We then hypothesized
that knockdown of PKD1 in neurons would reduce
both the NMDAR phosphorylation and the inhibition
of NMDAR activity induced by NMDAR internalization if
endogenous PKD1 indeed acted as a critical downstream
factor activated by the event of NMDAR internalization.
Knockdown of PKD1 does not affect NMDAR
internalization, but prevents both the enhancement of
NMDAR phosphorylation and the inhibition of remaining
(non-internalized) surface NMDARs induced by NMDAR
internalization
We found that infection with PKD1 shRNA (Open Biosys-
tems/Thermo Fisher Scientific, Lafayette, CO; Additional









































































Fig. 5 The event of NMDAR internalization activates PKD1. Upper blots (from left to right) shown in (a) represent examples of Western analysis
with an antibody for phosphorylated T638 and T641 in PKC-α and β, phosphorylated S606 in PKC-β, phosphorylated T538 in PKC-θ or phosphorylated
T410 and T403 in PKC-ζ and λ. Upper blots in (b and c) show examples of experiments with antibodies recognizing phosphorylated T197 in PKA and
phosphorylated S916 in PKD1, respectively. Lower blots in (a - c) show GluN1 proteins detected in each experiment. The ratio of band
intensity showing phosphorylated enzymes versus that showing GluN1 subunit protein detected in the same lysates was normalized with
the ratio in neurons treated with culture medium (M, control, =100 %, dashed line in d). Bar graphs in (d) show summary data (mean ± SEM) of the
normalized ratios. For blotting analysis shown in (e), PKD1 was immunoprcipitated with an antibody recognizing both phosphorylated/active
and non-phosphorylated/inactive PKD1 from neurons treated with agents in bath as indicated. The same filters were stripped and successively
probed with antibodies recognizing active PKD1 (upper blot) and total PKD1 (lower blot). The ratio of band intensity of active versus that of
total PKD1 was normalized to the ratio in neurons treated only with culture medium (M, control). Bar graphs show summary data. #, ##: P < 0.05, 0.01
(independent t-test) in comparison with control
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of endogenous PKD1 without affecting the expression
of other proteins such as PKC-α (Additional file 7:
Figure S7B) when compared with those following infec-
tion with control shRNA (Additional file 7: Figure S7B).
Compared with those found in neurons without infection
with shRNA (see Additional file 1: Figure S1), the knock-
down of PKD1 did not produce any change in the intern-
alization of NMDARs induced by treatment with DHPG
or with high NMDA/glycine (Fig. 6a–c). However, PKD1
shRNA infection prevented the increases in the serine
phosphorylation of both the GluN2A (Fig. 6d) and
GluN2B (Fig. 6e) subunits whereas infection of control
shRNA did not alter the increases in the serine phosphor-
ylation (Fig. 6f and g) induced by DHPG or high NMDA/
glycine treatment.
We then examined the effects of knocking down
PKD1 on NMDAR-mediated single channel activity
(Fig. 7). In neurons infected with PKD1 shRNA, Po, to,
Bs, Cs, and Sc of recorded NMDARs (n = 6 patches)
were 0.033 ± 0.013, 1.5 ± 0.07 ms, 2.3 ± 0.2 ms, 5.9 ±
1.4 ms, 53.1 ± 21 ms, respectively. Consistent with
findings in neurons treated with staurosporine (1 μM)
(data not shown), no significant reduction in Po, to, Bs,
Cs or Sc was found after bath application of 100 μM
glycine in the presence of 1 mM NMDA (Fig. 7a) or
DHPG at 50 μM (Fig. 7b). In contrast, the bath application
of glycine or DHPG produced significant inhibition of
NMDAR activity recorded in neurons infected with con-
trol shRNA (Fig. 7c and d). These data evidenced that the
knockdown of PKD1 prevented both the increase in serine
phosphorylation and the inhibition of remaining surface
NMDARs following internalization of remote NMDARs.
To determine the functional significance of the modu-
lation of non-internalized surface NMDARs, miniature
a b c
gfed
Fig. 6 Knockdown of PKD1 does not affect NMDAR internalization but prevents the NMDAR internalization-induced increases in serine phosphorylation
of surface NMDARs. a - c DHPG or high NMDA/glycine (N + G) induced NMDAR internalization in neurons infected with PKD1 shRNA.
After biotinylation of these neurons, GluN1 (a), GluN2A (b) or GluN2B (c) subunit protein was immunoprecipitated. The same filters were stripped and
successively probed with HRP-conjugated streptavidin (Strep, upper blot) and an antibody against the GluN1 (a), GluN2A (b) or GluN2B (c) subunit
(lower blots). Bar graphs show summary data (mean ± SEM) of the normalized ratios between biotinylated and total GluN1, GluN2A or GluN2B subunit
proteins detected. NMDAR phosphorylation induced by bath application of DHPG or N + G in neurons infected with PKD1shRNA is shown in
(d and e). NMDAR phosphorylation in neurons infected with control shRNA (Ctl. shRNA) is shown in (f and g). The same filter shown in (d or e) was
stripped and successively probed with anti-pS1416 (top blots), anti-pSer (middle blots) and GluN2A antibody (bottom blots). The anti-pSer (upper blots)
and GluN2B antibody (lower blots) were respectively used to probe the filters shown in (e and g). Bar graphs show summary data (mean ± SEM) of
the normalized ratios between phosphorylatd and total GluN2A (d and f) or GluN2B (e and g) protein. Open and filled bars in (d - g) show
changes detected with anti-pSer and anti-pS1416 antibodies, respectively. #, ##: P < 0.05, 0.01 (independent t-test) in comparison with control
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excitatory post-synaptic currents (mEPSCs) in cultured
hippocampal neurons without or with knockdown of
PKD1 were recorded (Fig. 7e and f; Additional file 8:
Figure S8). Consistent with previous studies [13–16],
bath applying DHPG significantly reduced both the
NMDAR and AMPAR-mediated mEPSC components
in neurons without shRNA infection (Control, Fig. 7e
and f; Additional file 8: Figure S8). DIP, which was
applied into neurons through inclusion of the peptide
in the intracellular solution filling recording pipettes,
prevented the inhibition of both the NMDAR-and
AMPAR-mediated mEPSCs following DHPG applica-
tion (Fig. 7e and f ). Interestingly, PKD1 knockdown
blocked the inhibition of mEPSCs induced by NMDAR
internalization but did not affect the effect induced by
AMPAR internalization (Fig. 7e and f; Additional file 8:
Figure S8D–F). Infection with control shRNA did
not produce any effect (Fig. 7e and f; Additional file 8:
Figure S8G - I). These findings not only strongly suggest
that PKD1 may be selectively activated by NMDAR in-
ternalization but also demonstrate that the activity of
remaining surface NMDARs plays an important role in
the regulation of NMDAR-mediated synaptic activity by
NMDAR internalization. Altogether, we conclude that reg-
ulated NMDAR internalization causes down-regulations
of the activity of remaining (non-internalized) surface
NMDARs and the synaptic transmission through serine
phosphorylation of remaining surface NMDARs induced
by PKD1 activation (Fig. 8).
Discussion
In order to determine whether the functional properties
of remaining surface NMDARs, which are not internalized,














































































































































Fig. 7 Knockdown of PKD1 blocks the NMDAR internalization-induced inhibition of remaining surface NMDARs. a and b show examples of records of
Po (bin: 10 s) and summary data (Bar graph) of relative changes in overall Po, to, Bs, Cs and Sc when compared with that before bath application of 100
μM glycine (a) or 50 μM DHPG (b) (control, dashed line) in neurons infected with PKD1 shRNA. c and d show examples of records of Po and
summary data of relative changes in NMDAR channels activity in neurons infected with control shRNA (Ctl. shRNA). e shows examples of
averaged mEPSC traces recorded from neurons before and after bath application of DHPG. Bar graphs in f show relative changes in AMPAR
and NMDAR components of mEPSCs when compared with control (dashed line) before bath application of DHPG. *,**P < 0.05, < 0.01 (paired
t-test) in comparison with control before glycine or DHPG application
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conducted single channel recordings in the cell-attached
configuration. Previous studies have demonstrated that
NMDAR activity can be regulated by remote NMDARs
through intracellular signaling pathways [20, 21, 59]. The
current work demonstrates that internalization of remote
NMDARs causes changes in the activity of NMDARs
remaining on the cell surface. This conclusion is also sup-
ported by the findings that the application of the protein
kinase inhibitor staurosporine (data not shown), or the
knock-down of PKD1 did not prevent NMDAR internaliza-
tion but did block the increase of serine phosphorylation in
NMDARs and the inhibition of their activity. If the inhib-
ition of NMDAR channels recorded within membrane
patches following the bath application of DHPG or high
NMDA/glycine were caused by internalization of the re-
corded NMDAR channels, the bath application of either
DHPG or high NMDA/glycine to neurons treated with
either staurosporine or PKD1 shRNAs would still induce
down-regulations of NMDA channel activity recorded
within membrane patches.
It was thought until now that through reducing the
number of active receptor/channels located on the cell
surface, the regulated receptor/channel internalization
reduced the receptor/channel-mediated responses. Our
single channel data showed that the NMDAR intern-
alization, which reduced the amount of NMDARs
expressed on the neuronal surface, also led to inhibition of
the activity of remaining surface NMDARs. Furthermore,
the inhibition of activity was mediated through intracellu-
lar PKD1 signaling as we found that knockdown of PKD1
prevented the inhibition of single channel activity of
remaining NMDARs induced by NMDAR internalization,
and also prevented the reduction of synaptic NMDAR
responses (Fig. 7f ). Thus, our findings imply a novel
mechanism to reduce NMDAR-mediated responses
following NMDAR internalization in addition to decreased
cell-surface expression of the receptors. The inhibition of
remaining surface NMDARs also plays a critical role
in the regulation of NMDAR-mediated responses by
NMDAR internalization.
A large amount of data have demonstrated that the
activation of group 1 metabotropic glutamate recep-
tors through application of DHPG is an important
mechanism underlying the induction of long-term de-
pression of AMPAR-mediated synaptic responses (LTD)
[10, 14–17, 60]. More detailed studies have shown that
phosphorylation of the GluA1 subunit of AMPARs by
PKA may promote AMPAR surface insertion and de-
creases the endocytosis of the receptor, leading to in-
creases in AMPAR on cell surface [61]. Two receptor
pathways are proposed to drive the endocytosis of distinct
populations of AMPARs: 1) NMDARs activation induces
the endocytosis of rapidly cycling surface AMPARs not
directly associated with GRIP1/2; 2) mGluR activation in-
duces the endocytosis of non-cycling GRIP-bound surface
AMPARs [60]. DHPG-induced LTD may, or may not,
require activation of NMDA receptors, depending upon
the experimental conditions [10, 17].
NMDARs are well-known to undergo two types of
regulated internalization [11] – homologous and heterol-
ogous. Homologous internalization can be induced by
treating with high NMDA/glycine, which induces intern-
alization of NMDARs but not other receptors such as
AMPARs [12]. Heterologous internalization can be in-
duced by application of DHPG, which may also induce
endocytosis of AMPARs and mGluRs [13–17]. Our data
showed that through the activation of PKD1, remaining
surface NMDARs were inhibited by regulated endocyto-
sis of NMDARs in heterologous and also in homologous
models. Moreover, in the heterologous model the knock-
down of PKD1, had no effect on the inhibition of
AMPAR-mediated responses but significantly blocked
the inhibition of NMDAR-mediated responses. Thus,
PKD1 signaling activated by regulated NMDAR endo-
cytosis appears to differentially inhibit NMDARs but not
on AMPARs.
The phenomenon discovered in our work underlying the
regulation of remaining surface receptor/channels by the
endocytosis of the same type receptor/channels might there-
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Fig. 8 Effects of regulated NMDAR internalization. A diagram shows that the regulated internalization of cell surface NMDARs not only reduces
the number of NMDARs expressed on the cell surface but also causes phosphorylation and an inhibition of remaining (non-internalized) surface
NMDARs through PKD1. Extr.: Extracellular, Intr.: Intracellular
Fang et al. Molecular Brain  (2015) 8:75 Page 10 of 18
how PKD1 signaling is activated by NMDAR endocytosis
and what role, if any, is played by other receptors such as
AMPAR in the PKD1 activation remains to be clarified.
Further clarifying the mechanisms underlying the regula-
tion of remaining surface receptor/channels is challenging
and required for understanding of the principal biological
event: internalization of cell-surface receptor/channels.
Altogether, we conclude that the regulated NMDAR in-
ternalization causes down-regulations of the activity of
remaining (non-internalized) surface NMDARs and the
synaptic transmission through serine phosphorylation of
remaining surface NMDARs induced by PKD1 activa-
tion (Fig. 8).
Previous studies, including ours, have shown that tyro-
sine phosphorylation may enhance NMDAR activity
while tyrosine dephosphorylation may down-regulate
NMDAR activity [62–66] and trigger NMDAR internal-
ization [37, 67–71]. Striatal-enriched protein tyrosine
phosphatase (STEP) has been identified as an important
tyrosine phosphatase promoting NMDAR endocytosis
[37, 67–71]. The tyrosine residue 1472 in the GluN2B
subunit has been clarified as a critical site underlying the
regulation of NMDAR trafficking by tyrosine phosphor-
ylation [65, 66, 72]. In order to identify mechanisms
underlying the NMDAR endocytosis-induced gating in-
hibition of remaining cell surface NMDARs, we required
a model in which the regulated receptor endocytosis will
not be altered. Since changes in tyrosine phosphoryl-
ation may alter NMDAR endocytosis [37, 65–72], and a
significant enhancement in serine phosphorylation of
NMDARs on the cell surface was noted following reg-
ulated NMDAR endocytosis, in this work we focused
on the effects produced by phosphorylation at serine
residue(s) of NMDARs. Thus, roles played by tyrosine
phosphorylation in the regulation of remaining surface
NMDARs remains to be clarified.
C-termini of NMDAR subunits are known to be critic-
ally involved in regulation of both the NMDAR internal-
ization and gating [36–38, 73, 74]. The present work
provided direct evidence showing that the C-tail portion
after aa 857 in the GluN2B, but not in the GluN2A subunit,
is required for the regulated NMDAR internalization. Tak-
ing advantage that the truncation of the C-tail after aa 857
did not affect the internalization of GluN1-1a/GluN2A1-
857 receptors, S1416 in the GluN2A subunit was identified
to be critically involved in the serine phosphorylation
and gating regulation induced by NMDAR internaliza-
tion. In contrast, the portion after aa 857 in the GluN2B
subunit is likely involved in both the regulated NMDAR
internalization and the internalization-induced gating
regulation. Since the truncation after aa 857 in the
GluN2B subunit blocked the internalization of GluN1-
1a/GluN2B1-857 receptors, the residue(s) involved in
the increased serine phosphorylation in the GluN2B
subunit induced by NMDAR internalization still needs
to be characterized.
Taking together with findings that the application of
active recombinant PKD1 protein into cells produced
inhibition of NMDAR currents and that this inhibition
was blocked by S1416F mutation in the GluN2A sub-
unit or C-tail truncation in the GluN2B subunit, we
conclude that regulated NMDAR internalization acts as
an upstream signal which activates the downstream
PKD1 and thereby causes the phosphorylation and
down-regulation of remaining surface NMDARs (Fig. 8).
PKD1 is a ubiquitously expressed serine/threonine kin-
ase, and was originally identified as PKC-μ [49, 50], an
atypical isoform of PKC. PKD1 is found to play import-
ant roles in fission of vesicles at the Golgi compart-
ment, coordination of cell migration and invasion,
regulation of gene transcription and surface protein
translocation [49, 50, 75, 76]. PKD1 can be activated
through multiple mechanisms including PKC phos-
phorylation [77], activation of G-protein-coupled re-
ceptors [49, 78, 79] and ligand-gated channels [80]. The
C-terminal autophosphorylation sites in PKD1 is part
of the PDZ binding motif of postsynaptic density-95
(PSD95), which thereby provides a mechanism for PKD1
to interact with proteins located at neuronal surface [81].
In neurons PKD1 has been found to be involved in the
regulation of dendritic trafficking and the establishment of
neuronal polarity [49, 50], and the PKD homolog Dkf-2 is
found to be involved in the regulation of associative
learning and memory in Caenorhabditis elegans [82].
The NMDAR internalization-induced inhibitions of
both the remaining surface NMDAR activity and the
NMDAR-mediated synaptic response can be significantly
reduced by knockdown of PKD1. This finding has not
only revealed a role played by remaining surface NMDARs
in the regulation of NMDAR functions by NMDAR
internalization, but also provided a novel mechanism
that quantity changes in cell surface receptors may
down-regulated the receptor-mediated whole-cell re-
sponse through depressing the activity of non-internalized
surface receptors.
Conclusion
Thus, we conclude that regulated internalization of cell
surface NMDARs not only reduces the number of
NMDARs expressed on the cell surface but also causes
an inhibition of the activity of non-internalized NMDARs
through the activation of PKD1 (Fig. 8). The function of
remaining surface NMDARs play critical roles in the regu-
lation of neuronal activity by NMDAR endocytosis. As
such, further clarifying the signaling pathway(s) under-
lying NMDAR internalization-induced PKD1 activation
and the mechanism and function of the regulation of
remaining surface receptors will be essential for
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developing new approaches treating neurological changes
associated with receptor trafficking.
Methods
All animal experiments were conducted following the
guidelines of the Canadian Council on Animal Care and
the NIH, and approved by the Animal Care Committee
at University of Toronto and Animal Care and Use
Committee at Florida State University.
Tissue culture, cDNA construction and transfection
Methods for primary neuron culture and HEK293 cell
culture have been described previously [20, 83, 84].
Briefly, a block of cortical or hippocampal tissue was
dissected from Wistar rat embryos (18 days gestation) at
4 °C. For biochemical experiments, a high density of dis-
sociated cortical or hippocampal neurons (approximately
7 × 104 cells/cm2) or HEK293 cells (6 × 104 cells/cm2)
was plated onto 60 mm culture dishes coated with poly-
D-lysine. Neurons were cultured with Neurobasal™ media
(Invitrogen, Grand Island, NY) supplemented with
B27 (2 %), bFGF2 (2 ng/mL) and L-glutamine (0.5 mM),
and HEK293 cells with Dulbecco’s Modified Eagles Media
(DMEM) (Gibco-BRL, Grand Island, NY) supplemented
with 10 % fetal bovine serum. For imaging experiments, a
low density of cells (approximately 3 × 103 cells/cm2) was
cultured on glass cover-slips (MatTek, Ashland, MA). For
electrophysiological recordings in neurons a low density
culture of hippocampal neurons was plated in poly-D-
lysine-coated dishes with Neurobasal™ media as men-
tioned above, or on collagen-coated dishes with minimum
essential media (MEM) supplemented with 10 % horse
serum. Since no difference was found in electrophysio-
logical studies of neurons cultured with MEM versus
those with Neurobasal™ media, the data were pooled.
For electrophysiological recordings in HEK293 cells,
low density culture was maintained in DMEM supple-
mented with 10 % fetal bovine serum.
Methods for constructing cDNAs of NMDAR subunits
were described in our previous reports [31, 83]. The
truncations in C-tail of the GluN2A or GluN2B subunit
were carried out by introducing stops using site-directed
mutagenesis. The mutation of serine to phenylalanine
was performed to identify phosphorylation site(s) in the
GluN2A subunit. For cDNA transfection HEK293 cells
were incubated with LipoD293™ (SignaGen, Rockville,
MD) and cDNAs of PSD95 (0.4 μg), GluN1-1a (1–2 μg)
and GluN2A or GluN2A mutants (2–4 μg), or GluN2B
or GluN2B mutants (2–4 μg). After a 5 h incubation
with the cDNAs and transfection agents cells were incu-
bated with DMEM supplemented with 10 % fetal bovine
serum and AP5 (500 μM) and maintained for 48 h
before experiments.
Surface protein internalization assay
Surface protein internalization induced by bath treatment
with NMDA (1 mM) and glycine (100 μM) (defined as
high NMDA/glycine in this article) for 10 min or with
DHPG (50 μM) for 5 min were determined with bio-
chemical assays and imaging observations. For bio-
chemical assays, cell surface proteins were biotinylated
with cell impermeant non-cleavable EZ-Link Sulfo-NHS-
LC-LC-Biotin (Pierce, Appleton, WI), as described previ-
ously [85, 86]. In brief, cultured cells without treatment or
treated with vehicle (the standard extracellular solu-
tion for electrophysiological recordings, see below),
high NMDA/glycine (for 10 min) or DHPG (for 5 min) at
37 °C were transferred onto ice and washed three times
with ice-cold PBS and incubated with ice-cold PBS con-
taining 1 mg/ml biotin for 1 h at 4 °C. The unbound biotin
was removed through three washes with ice-cold PBS.
Cells were then harvested in 1.5 ml of ice-cold PBS with a
rubber policeman and lysed in 400 μl of ice-cold cell lysis
buffer containing 50 mM Tris–HCl (pH 7.6), 150 mM
NaCl, 1 % Igepal CA-630, 0.5 % sodium deoxycholate,
0.1 % SDS, 2 mM EDTA, 1 mM sodium orthovanadate,
and the protease inhibitors Pepstatin A (20 μg/ml),
Leupeptin (20 μg/ml), Aprotinin (20 μg/ml) and Phe-
nylmethylsulfonyl fluoride (1 mM). The homogenates
were centrifuged at 20,000× g for 5 min at 4 °C.
Then, the supernatant (300 μl) was incubated with an
NMDAR subunit antibody or with NeutrAvidin agarose
(Thermo Scientific, Rockford, lL) to precipitate NMDAR
subunit protein or biotinylated protein. NMDAR proteins
expressed on cell surface were determined through detect-
ing biotinylated NMDAR subunit protein in NMDAR
immunoprecipitates or NMDAR proteins in pull downed
proteins with NeutrAvidin agarose.
For image analysis, neurons cultured on glass cover-
slips were biotinylated as mentioned above. Following
treatment with the vehicle, high NMDA/glycine (for 10
min) or DHPG (for 5 min) at 37 °C, neurons were incu-
bated with biotin for 1 h at 4 °C. And then neurons were
fixed with ice-cold 4 % paraformaldehyde, permeabilized
with 0.1 % Triton X-100 and incubated with an antibody
against the GluN1 (1:500, BD Pharmingen), GluN2A
(1:1000, Rabbit, Santa Cruz), or GluN2B (1:500, Rabbit,
Invitrogen) subunit. Biotinylated neuronal surface pro-
teins were visualized with streptavidin-conjugated Alexa
488 (green), and NMDAR subunit proteins were visual-
ized with Alexa 568-conjugated goat anti-mouse or Don-
key anti-rabbit IgG. Background staining was removed
by thorough washing with PBS. Coverslips were then
mounted using Fluoromount® (Sigma). Z-stack images of
fluorescence staining were taken under an Axiovert 200
M fluorescence microscope (Carl Zeiss) equipped with
CCD camera (Orca-ER, Hamamatsu) using software
AxioVision 4.5 (Carl Zeiss). Co-localization of staining
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of the GluN1, GluN2A or GluN2B subunit with biotinyl-
ated cell surface proteins was analyzed using NIH-
ImageJ software (NIH, Bethesda, ML) [87]. Ratios of
pixel numbers showing the co-localized GluN1, GluN2A,
or GluN2B subunit versus total GluN1, GluN2A or
GluN2B subunit were calculated, respectively.
Synaptic plasma membrane (LP1) preparation
To determine the effect of NMDAR endocytosis on
phosphorylation of surface NMDAR proteins, the synap-
tic plasma membrane (LP1) [24, 30] was isolated as de-
scribed previously [31]. In brief, cultured neurons were
harvested and homogenized in ice cold homogenization
buffer containing (mM): sucrose (320), HEPES (4, pH
7.4), NaF (50), sodium pyrophosphate (10, EMD), so-
dium glycerophosphate (20, Calbiochem), sodium ortho-
vanadate (1), PMSF (0.1), aprotinin (20 μg/ml, MP),
leupeptin (20 μg/ml, MP), and pepstatin (20 μg/ml, MP).
The homogenate was spun at 1000x g for 15 min at 4 °C
to remove the nuclear pellet and other large debris (P1).
The supernatant (S1) was collected for further experi-
ments to yield the crude synaptosomal fraction (P2)
which was subsequently lysed by hypoosmotic shock in
0.5 ml of ice cold 4 mM HEPES (pH 7.4) plus protease/
phosphatase inhibitors and three strokes of an eppendorf
tube homogenizer. It was kept on ice for 30 min to en-
sure complete lysis. By using a pasteur pipette, the lysate
was layered on top of a discontinuous gradient contain-
ing 0.8 to 1.0 to 1.2 M sucrose (top to bottom) in a clear
tube, and was centrifuged at 150,000x g for 2 h at 4 °C.
LP1 was recovered in the layer between 1.0 and 1.2 M
sucrose, and then it was diluted to 0.32 M sucrose by
adding 2.5 volume of 4 mM HEPES pH 7.4. The synaptic
plasma membrane was pelleted by centrifugation at
150,000 g for 45 min at 4 °C and then resuspended in
cell lysis buffer (mM): Tris–HCl (50, pH 7.4), NaCl
(150), 1 % Igepal CA-630, 0.5 % deoxycholate, 0.1 %
SDS, EDTA (2), NaF (50), sodium pyrophosphate (10),
sodium glycerophosphate (20), sodium orthovandate (4);
pepstatin A (20 μg/ml), leupeptin (20 μg/ml), aprotin
(20 μg/ml), PMSF (1). The protein concentration was
determined by Bradford assay. NMDAR subunit proteins
were immunopurified from the LP1 fraction and their
serine phosphorylation was examined by anti-pSer anti-
body (Invitrogen) in Western blot analysis.
Immunoprecipitation and western blot
Immunoprecipitation and Western blotting were per-
formed as described previously [31, 83]. Solubilized pro-
teins (cell lysate or LP1 extracts) were incubated with
antibodies overnight at 4 °C, followed by incubation with
25 μl of protein A-sepharose beads (Amersham Biosci-
ences, Piscataway, NJ) for 3 h at 4 °C. The immunopre-
cipitates were washed 3 times with ice-cold cell lysis
buffer, resuspended in 2X Laemmli sample buffer (120
mM Tris–HCl pH6.7, 4 % SDS, 10 % glycerol, 0.04 mg/ml
bromophenol blue, 5 % 2-mercaptoethanol), and boiled
for 5 min. Antibodies used for immunoprecipitation were:
anti-GluN1 (mouse, 0.5 μg, BD Bioscience, San Jose, CA),
anti-GluN2A C-terminal (rabbit, 1.5 μg, EMD Millipore,
Billerica, MA), anti-GluN2A N-terminal (rabbit, 2 μg,
Santa Cruz Biotech., Santa Cruz, CA), anti-GluN2B N-
terminal (rabbit, 0.5 μg, Invitrogen) and anti-PKD1 (rabbit,
1 μg, Cell Signaling, Danvers, MA). To pull down biotinyl-
ated protein homogenates were centrifuged at 15,000x g
for 15 min. 20 μl of supernatant was used to measure total
GluN1, GluN2A or GluN2B. 260 μl of supernatant was in-
cubated with 100 μl of 50 % NeutrAvidin agarose (Thermo
Scientific) at 4 °C for 3 h. The agarose beads were
washed three times with cell lysis buffer and the bound bi-
otinylated proteins were eluted from the beads in 40 μl of
2 × Laemmli sample buffer by boiling.
The majority of the gels used for the Western blot
analysis were 7.5 % polyacrylamide SDS-PAGE gels with
Tris-glycine running buffer. Synthetic peptides of S1407-
H1419 or S1407-H1419 (pS1416) were loaded on precast
4–12 % Bis–Tris polyacrylamide gels with MES running
buffer (Invitrogen, Inc.) for the analysis of the specificity
of the anti-pS1416 antibody. The filters were stripped re-
peatedly and probed successively with various antibodies.
Antibody staining bands were visualized with Enhanced
Chemiluminescence (Bio-Rad, Hercules, CA) or Immo-
bilon (EMD Millipore). The band intensities were quan-
tified with NIH-imageJ software (NIH, Bethesda, ML).
Antibodies used in this study include anti-GluN1 (1:2000,
mouse, BD Pharmingen), anti-GluN2A C-terminal (1:1000,
rabbit, EMD Millipore), anti-GluN2A N-terminal (1:1000,
rabbit, Santa Cruz), anti- GluN2B (1:1000, rabbit, Invitro-
gen), anti-pSer (1:1000, rabbit, Invitrogen), anti-pS1416
(1:1000, rabbit), anti-Kv3.1 (1:500, rabbit, BD Bioscience),
anti-actin (1:4000, mouse), and antibodies recognizing the
phosphorylated S916 in PKD1 [56] (1:1000, rabbit), phos-
phorylated T197 in PKA [55] (1:1000, rabbit) and phos-
phorylated T638 and T641 in PKC-α and β [51] (1:1000,
rabbit), phosphorylated S606 in PKC-β [51] (1:1000,
rabbit), phosphorylated T538 in PKC-θ [52] (1:1000,
rabbit), phosphorylated T410 and T403 in PKC-ζ and λ
[53, 54] (1:1000, rabbit) were used to examine the activa-
tion status of these enzymes, respectively. All these anti-
bodies were purchased from the company, Cell Signaling.
To control variations which may occur from one ex-
periment to another, samples treated only with culture
medium were always tested as controls in each (or each
repeat) biochemical experiment. We conducted careful,
unbiased, densitometry analysis of all western blots by
using NIH-ImageJ software. The relative densitometric
intensities on the Western blots of the treated samples
compared to samples treated only with culture medium
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were calculated, and multiplied by 100, as “Percent of
Control”. These values were used to show the effects of
any treatment. Ratios of the protein band intensities of
the biotinylated GluN1, GluN2A or GluN2B subunit de-
tected with streptavidin versus that with the antibodies
were calculated to determine the amount of surface
NMDARs and normalized to the ratio detected in cells
treated only with culture medium conducted in parallel.
The immunoprecipitation experiments from non-
biotinylated tissues were conducted as negative controls.
Lentivirus production and neuronal infection
Lentiviral particle production and infection were per-
formed as recommended by the manufacture (Open Bio-
systems/Thermo Fisher Scientific, Pittsburgh, PA). For
Lentiviral particle production, HEK293T cells were co-
transfected with the Trans-Lentiviral packaging mix and
the transfer vector containing green fluorescent protein
(GFP) cDNA and the PKD1 shRNA (TGCTGTTGACAG
TGAGCGCATCGTTCACTGTGACCTCAAATAGTGAA
GCCACAGATGTATTTGAGGTCACAGTGAACGATAT




Thermo Fisher Scientific) as recommended by the manu-
facture (Open Biosystems/Thermo Fisher Scientific). The
virus-containing supernatants were collected 48–72 h post-
transfection, centrifuged and filtered through 0.45 μm low
protein binding filter with the approximate titer 1 × 106
transducing units per ml (Open Biosystems/Thermo Fisher
Scientific). The viral stock was aliquoted and stored
at −80 °C. Nine to ten days after plating, cultured neurons
were infected by adding the viral-supplemented medium
(stock) into culture medium (for biochemical experi-
ments: 1.25 ml/ml; for electrophysiological recordings:
0.03 ml/ml). Four to five hours after infection, neu-
rons were washed with 1X PBS and cultured for 7–10
days before electrophysiological or biochemical experi-
ments. According to image observation more than 80 % of
cells were infected.
Electrophysiological recordings
Methods for recordings of NMDA-evoked single-
channel or whole-cell currents, and mEPSCs have been
described previously [20, 59, 83, 84]. For single-channel
recordings, a standard extracellular solution was used
for all recordings conducted in cultured neurons, con-
taining (in mM): Na2SO4 (100), Cs2SO4 (10), CaCl2 (4.8),
HEPES (25), glucose (32), TTX (0.001), glycine (0.003),
bicuculline (0.01) and strychnine (0.01), pH: 7.35 and
osmolarity: 310–320 mOsm. Free Ca2+ concentration in
this solution was at 1.2 mM as confirmed by measure-
ment with a Ca2+ selective electrode (Thermo Electron
Corporation, Beverly, MA). To prevent cell damage during
NMDAR activation, in this solution, Cs+ and SO4
2−
replaced K+ and Cl−, respectively [88, 89]. Recording
electrodes were pulled to a diameter of 1–2 μm at
the tip and filled with the same extracellular solution
but containing NMDA (0.01 or 1 mM as indicated)
to evoke NMDAR-mediated single-channel currents (DC
resistance: 8–10 MΩ). For electrophysiological recordings,
the cultures were placed in a recording chamber on
an inverted microscope (Axiovert S200 TV, Carl Zeiss,
Oberkochen, Germany) equipped with 64 × Differential
Interference Contrast (DIC) System. The image was mag-
nified further by 30 x and displayed on a 17” TV monitor.
The morphology of the cell soma and major processes of
neurons were monitored. None of the bath solutions or
experimental manipulations produced significant changes
in size or shape of the cell soma and/or main processes.
Single-channel currents were recorded with a patch
potential of 70 mV from the reversal potential using an
AxoPatch 200B amplifier. Recorded electronic signals
were filtered at 10 KHz (−3 dB, 8 pole Bessel) and sam-
pled continuously onto a computer at 20 KHz with the
pClamp9 software (Molecule Device, Sunnyvale, CA).
Consistent with previous observations [59, 90], most
(80 %) recorded channels from neurons bathed with the
standard extracellular solution have main conductance
levels ranging from 40–60 pS, and for the remainder, the
main conductance levels were in the range of 10–30 pS.
The recorded currents could be abolished by bath applica-
tion of the lipophilic NMDAR channel blocker, MK-801
(2 μM), confirming that NMDAR-mediated currents were
recorded. [20, 59]. Since only one main conductance level
of channel openings was found in most patches, the
channel open probability and duration of channel
openings and closings were determined off-line by
using a 50 % crossing threshold. The distribution histo-
grams of the channel open and shut dwell-time (not in-
cluding those ≤ 0.1 ms) were binned (log bin density = 9)
and respectively fitted using Levenberg-Marquardt least-
squares method in pSTAT6 software (Molecule Device).
The usefulness of adding exponential components was
assessed using an F-test and also by visual inspection. We
calculated the durations of bursts, clusters and super-
clusters of channel openings [91], which were identified
according to critical times (tc) where each tc was defined
by 1-e-tc/τs = e-tc/τm (τs and τm: the time constants of short
and intermediate gap lengths) [59, 90].
To examine effects of DHPG application, after a 3 to 5
min period of control recordings, DHPG (50 μM) was
bath applied for 5 min and then recordings were contin-
ued for another 10 to 20 min. To examine effects of high
NMDA/glycine application, the extracellular solution
containing 1 mM NMDA was applied after the cell-
attached configuration was formed. Control recordings
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were conducted for 3–5 min in neurons bathed with the
extracellular solution containing 1 mM NMDA, and
then glycine (100 μM) was bath co-applied.
For whole-cell voltage-clamp recordings cells were
bathed with the same standard extracellular solution
mentioned above except that 10 μM glycine was applied
for recordings in HEK cells. Recording electrodes were
filled with intracellular solution composed of (in mM):
CsCl (145), BAPTA (0.5), HEPES (10), MgCl2 (2), K-ATP
(4), osmolarity 290–300 mOsm (DC resistance: 4–7
MΩ). NMDA-mediated whole-cell currents were evoked
by application of 1 mM NMDA dissolved in the extra-
cellular solution via a computer-controlled multi-barrel
fast-step perfusion system (SF-77B perfusion fast-step
system, Warner Instrument, Hamden, CT). Whole-cell
currents were recorded using Axopatch 200B amplifiers
(Molecular Devices, Sunnyvale, CA) under the voltage-
clamp condition at a holding potential of −60 mV except
where indicated. On-line data acquisition and off-line
analysis were performed using pClamp9 software (Mo-
lecular Devices). To determine effects produced by
intracellular delivery of PKD1 added in the intracellular
solution filling recording electrodes, recorded whole-cell
currents evoked by NMDA application were compared
with that recorded immediately after breakthrough
(defined as “0” min in this work).
Miniature excitatory post-synaptic currents (mEPSCs)
were recorded in cultured hippocampal neurons (follow-
ing the protocol shown in Fig. 7e; Additional file 8:
Figure S8A, D and G) under the voltage-clamp condition
at a holding potential of −60 mV. On-line data acquisition
and off-line analysis were performed using pClamp9 soft-
ware (Molecular Devices). The threshold for detection of
mEPSCs was approximately −4 pA, which was determined
with an all-point histogram assay, and optimized for each
cell so as to collect > 95 % of mEPSCs [83]. NMDAR-
mediated mEPSCs were identified by application of the
NMDAR antagonist AP5 (100 μM). Non NMDAR-
mediated mEPSC frequency and amplitude were analysed
with software Mini Analysis Program (Synaptosoft,
Decatur, GA). To determine charges (Q) mediated by
NMDARs and non-NMDARs, mEPSCs were averaged
after alignment of the rising edge using WinWCP software
(Strathclyde Institute of Pharmacy and Biomedical Sci-
ences, Glasgow, UK). Traces with noise artifacts or with
more than one mEPSC per 200 ms recording period were
not included. mEPSCs were averaged for each treatment
period (at least 30 traces). The charges mediated by non-
NMDARs and NMDARs were respectively calculated by
integrating currents mediated by these receptors, and
normalized to that measured before DHPG application.
In order to record NMDAR activity before, during
and/or after regulated NMDAR endocytosis, which was
induced by bath application of DHPG or high NMDA/
glycine, only one neuron or one patch from one neuron
in one culture dish was allowed to be tested. To sample
an “n” of 5 or more cells for one group of experiments,
at least 2 separated cultures were required. All chemicals
used in this work were obtained from Sigma (St. Louis,
MO) except for those as indicated.
Statistic analysis
Multiple tests for examining normality or variance of
data were performed to determine which type of statistic
tests could be used to examine differences between ex-
perimental groups. For comparisons of channel activity
before and/or after bath application of any agents, paired
two-tailed Student’s t-tests were performed. For compari-
sons of protein expression and phosphorylation with that
in the group of cells treated only with culture medium, in-
dependent two-tailed Student’s t-tests were performed.
Repeated measures analysis of variance (ANOVA) were
used for comparison of experiments involving time
courses. All data are expressed as mean ± SEM.
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